Zobrazeno 1 - 10
of 98
pro vyhledávání: '"İrfan Ç"'
Autor:
Osman K., Ahmet K., Hilmi T., İlker N.O., Ercan Ö., Devrim Ç., Murat S., Emre Ç., İlhan H., Mustafa G., Yüksel Ü., Bahiddin Y., Cihan E., Mehmet Ali N. Ş., Emrah E., Umut D., Zeynep O., Mehmet Ali K., Ali G., İvo G., Erkan Ö., Muhammet B.H., Bülent E., Selma D., Sernaz U., Mahmut G., Hakan G., İrfan Ç.
Publikováno v:
Balkan Journal of Medical Genetics, Vol 25, Iss 2, Pp 5-14 (2022)
The demographic and clinical characteristics of patients who have BRCA 1/BRCA 2 pathogenic/likely pathogenic variants may differ from their relatives who had BRCA-related cancer. In this study, we aimed to demonstrate the clinical and demographic fin
Externí odkaz:
https://doaj.org/article/c0cbaea0ff6d4a069d5e79ca2869ea80
Autor:
Irfan Cicin, Elizabeth R. Plimack, Howard Gurney, Raya Leibowitz, Boris Y. Alekseev, Francis X. Parnis, Avivit Peer, Andrea Necchi, Joaquim Bellmunt, Hiroyuki Nishiyama, Jason Clark, Mihaela Munteanu, Ritesh Kataria, Calvin Jia, Thomas Powles, Cora N. Sternberg
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Indoleamine 2,3-dioxygenase 1 (IDO1) levels correlate with poor outcomes in urothelial carcinoma (UC). IDO1 and programmed death-ligand 1 (PD-L1) are often co-expressed. Epacadostat is a potent and highly selective inhibitor of ID
Externí odkaz:
https://doaj.org/article/263d9199baf8485699909ce6591e41d9
Autor:
İrfan Çapan, Mohammed Hawash, Mohammed T. Qaoud, Levent Gülüm, Ezgi Nurdan Yenilmez Tunoglu, Kezban Uçar Çifci, Bekir Sıtkı Çevrimli, Yusuf Sert, Süleyman Servi, İrfan Koca, Yusuf Tutar
Publikováno v:
BMC Chemistry, Vol 18, Iss 1, Pp 1-21 (2024)
Abstract Background Carbazole-based molecules containing thiosemicarbazide functional groups are recognized for their diverse biological activities, particularly in enhancing therapeutic anticancer effects through inhibiting crucial pathways. These d
Externí odkaz:
https://doaj.org/article/6a8568a5ddab447bad0d4fd4b16ffda5
Autor:
Hatice Bolek, Cagatay Arslan, Mert Basaran, İrfan Cicin, Mustafa Ozguroglu, Deniz Tural, Yüksel Ürün
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEDurable complete response rates for metastatic renal cell carcinoma (mRCC) and metastatic bladder cancer (mBC) are low despite new therapy. Palliative care focuses on life extension and quality of life (QoL), not cure. This study aims to inves
Externí odkaz:
https://doaj.org/article/cb5cd9d0b8f74576a1727fb5374b5887
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Matthew P. Goetz, Irfan Cicin, Laura Testa, Sara M. Tolaney, Jens Huober, Valentina Guarneri, Stephen R. D. Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S. Rugo, Joyce O’Shaughnessy
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract In monarchE, adjuvant abemaciclib significantly improved invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS), with sustained benefit beyond the 2-year treatment period. Abemaciclib dose reductions were allowed to p
Externí odkaz:
https://doaj.org/article/1378a75d34cd4a89ad1255e30c08bb59
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 26, Iss 11, Pp 1326-1333 (2023)
Objective(s): Cadmium (CD) causes widespread and severe toxic effects on various tissues. Studies have shown that apoptosis, inflammation, and endoplasmic reticulum stress play a role in organ damage caused by CD. Phenolic compounds with strong antio
Externí odkaz:
https://doaj.org/article/81f78adef1e440c881c5abfdeb755cd6
Autor:
Likun Chen, Jose David Gomez Rangel, Timucin Cil, Xingya Li, Irfan Cicin, Yihong Shen, Zhihua Liu, Ozgur Ozyilkan, Bondarenko Igor, Jun Chen, Kostiuk Oleksandr, Zhendong Chen, Helong Zhang, Ziyi Fu, Qingfeng Dong, Shuqiang Song, Jin‐Chen Yu, Li Zhang
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20847-20863 (2023)
Abstract Background BAT1706 is a proposed biosimilar of bevacizumab (Avastin®). We aimed to compare the efficacy and safety of BAT1706 with that of EU‐sourced reference bevacizumab (EU‐bevacizumab) in patients with advanced nonsquamous non‐sma
Externí odkaz:
https://doaj.org/article/81f12a95ae2a40989aaa39d8ab3f0483
Autor:
Osman, K., Ahmet, K., Hilmi, T., İlker, N.O., Ercan, Ö., Devrim, Ç., Murat, S., Emre, Ç., İlhan, H., Mustafa, G., Yüksel, Ü., Bahiddin, Y., Cihan, E., Mehmet Ali, N. Ş., Emrah, E., Umut, D., Zeynep, O., Mehmet Ali, K., Ali, G., İvo, G., Erkan, Ö., Muhammet, B.H., Bülent, E., Selma, D., Sernaz, U., Mahmut, G., Hakan, G., İrfan, Ç.
Publikováno v:
Balkan Journal of Medical Genetics; December 2022, Vol. 25 Issue: 2 p5-14, 10p
Autor:
İrfan Çapan, Mohammed Hawash, Mohammed T. Qaoud, Levent Gülüm, Ezgi Nurdan Yenilmez Tunoglu, Kezban Uçar Çifci, Bekir Sıtkı Çevrimli, Yusuf Sert, Süleyman Servi, İrfan Koca, Yusuf Tutar
Publikováno v:
BMC Chemistry, Vol 18, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/776e8b9b72a847ffad4f9d33f6c6464d